Utilization trends of respiratory medication in premature infants discharged on home oxygen therapy

2020 ◽  
Vol 55 (6) ◽  
pp. 1359-1365
Author(s):  
Heather White ◽  
Alice Berenson ◽  
Javed Mannan ◽  
Henry A. Feldman ◽  
Lawrence Rhein ◽  
...  
Keyword(s):  
Premature Infants ◽  
Oxygen Therapy ◽  
Home Oxygen Therapy

scholarly journals Inhaled nitric oxide (iNO) for preventing prematurity-related bronchopulmonary dysplasia (BPD): 7-year follow-up of the European Union Nitric Oxide (EUNO) trial

2021 ◽  
Vol 49 (1) ◽  
pp. 104-110
Author(s):  
Anne Greenough ◽  
Fabrice Decobert ◽  
David Field ◽  
Mikko Hallman ◽  
Helmut D. Hummler ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Bronchopulmonary Dysplasia ◽  
Premature Infants ◽  
Oxygen Therapy ◽  
Well Being ◽  
Inhaled Nitric Oxide ◽  
Current Evidence ◽  
Home Oxygen Therapy

AbstractObjectivesMost studies of inhaled nitric oxide (iNO) for prevention of bronchopulmonary dysplasia (BPD) in premature infants have focused on short-term mortality and morbidity. Our aim was to determine the long-term effects of iNO.MethodsA 7-year follow-up was undertaken of infants entered into a multicenter, double-blind, randomized, placebo-controlled trial of iNO for prevention of BPD in premature infants born between 24 and 28 weeks plus six days of gestation. At 7 years, survival and hospital admissions since the 2-year follow-up, home oxygen therapy in the past year, therapies used in the previous month and growth assessments were determined. Questionnaires were used to compare general health, well-being, and quality of life.ResultsA total of 305 children were assessed. No deaths were reported. Rates of hospitalization for respiratory problems (6.6 vs. 10.5%, iNO and placebo group, respectively) and use of respiratory medications (6.6 vs. 9.2%) were similar. Two patients who received iNO and one who received placebo had received home oxygen therapy. There were no significant differences in any questionnaire-documented health outcomes.ConclusionsiNO for prevention of BPD in very premature infants with respiratory distress did not result in long-term benefits or adverse long-term sequelae. In the light of current evidence, routine use of iNO cannot be recommended for prevention of BPD in preterm infants.

Does Recorded Oximetry Utilizing a Consensus Based Algorithm Compare to Polysomnography in Discontinuing Home Oxygen Therapy in Premature Infants

2021 ◽  
Author(s):  
Heather White ◽  
Celia Sobelman ◽  
Ted Kremer ◽  
Austin Lee ◽  
Lawrence M. Rhein ◽  
...  
Keyword(s):  
Premature Infants ◽  
Oxygen Therapy ◽  
Home Oxygen Therapy

scholarly journals Home Oxygen Therapy: The Jury is Still in Session

2004 ◽  
Vol 24 (2) ◽  
pp. 59-61 ◽  
Author(s):  
Ann C Halbower ◽  
Sharon A McGrath
Keyword(s):  
Oxygen Therapy ◽  
Home Oxygen Therapy

Factors influencing the compliance of patients using oxygen concentrators for long-term home oxygen therapy

1990 ◽  
Vol 84 (4) ◽  
pp. 331-333 ◽  
Author(s):  
Martin J. Walshaw ◽  
Richard Lim ◽  
Christopher C. Evans ◽  
Charles R.K. Hind
Keyword(s):  
Oxygen Therapy ◽  
Home Oxygen Therapy ◽  
Factors Influencing

Nexobrid Treatment for Burn Injuries in Patients With Chronic Obstructive Pulmonary Disease and Home Oxygen Therapy

2021 ◽  
Author(s):  
Marc Daniels ◽  
Jan Philipp Stromps ◽  
Wolfram Heitzmann ◽  
Jennifer Schiefer ◽  
Paul Christian Fuchs ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Oxygen Therapy ◽  
Burn Injuries ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Specific Patient ◽  
Home Oxygen Therapy ◽  
Increased Risk ◽  
Enzymatic Debridement

Abstract There is an increased risk for burn injuries associated with home oxygen therapy of patients with chronic obstructive pulmonary disease since 10 to 50 % of these patients continue to smoke. Enzymatic eschar removal of facial burns is gaining popularity but intubation of this specific patient group often leads to prolonged weaning and can require tracheostomy. This study dealt with the question if enzymatic debridement in these patients can also be performed in analgosedation. A selective review of the literature regarding burn trauma associated with home oxygen use in patients with COPD was performed, as well as a retrospective analysis of all patients with burn injuries associated with home oxygen use and chronic obstructive pulmonary disease that were admitted to the study clinic. In the literature 1746 patients with burns associated with home oxygen use are described, but none of them received enzymatic debridement. In this study seventeen patients were included. All three patients in this study with facial full-thickness burn injuries received enzymatic debridement. The mortality rate in this cohort was 17.6 % (3/17). Up to date, there is limited experience performing regional anesthesia debridement in patients with COPD. This is the first manuscript describing the use of enzymatic debridement in patients with COPD and home oxygen therapy. We could confirm other studies that intubation of these patients leads to prolonged ventilation hours and increases the probability for poor prognosis. Therefore, we described the treatment of enzymatic debridement in analgosedation without intubation.

scholarly journals Evaluation of the association of adherence to long-term home oxygen therapy and clinical markers and five-year mortality in patients with Chronic obstructive pulmonary disease

2020 ◽  
Vol 46 (6) ◽  
pp. e20190158-e20190158
Author(s):  
Vitória Klein Marcondes ◽  
Thais Sayuri Kuwazuru ◽  
Luiz Paulo Corrêa e Silva ◽  
Talita Jacon Cezare ◽  
Estefânia Aparecida Thome Franco ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Oxygen Therapy ◽  
Chronic Obstructive ◽  
Clinical Markers ◽  
Obstructive Pulmonary Disease ◽  
Home Oxygen Therapy
Sign in / Sign up

Export Citation Format

Share Document